Combinational strategy for high-performance cancer chemotherapy
The clinical outcomes of conventional mono-chemotherapy of cancers are usually far from satisfactory due to some issues such as tumor heterogeneity and resistance to chemotherapeutic drugs. With the increasing knowledge of molecular signal pathways and pathological mechanisms involved in the initiat...
Saved in:
Published in | Biomaterials Vol. 171; pp. 178 - 197 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!